Anticoagulation Clinical Trial
Official title:
Association Between Socioeconomic Factors and Use of Direct Oral Anticoagulants Versus Standard of Care (Warfarin) in Patients With Non-valvular Atrial Fibrillation in Sweden
The healthcare system in Sweden is publicly funded and aims to provide equal access to care
irrespective of socioeconomic status. This includes ensuring equity in drug treatment.
Socioeconomic disparities have been shown to influence patient management and health outcomes
in certain Swedish populations. The Swedish Board of Health and Welfare has stated that the
prescription of new drugs, which are more expensive than generic standard of care drugs,
might be influenced by patients' socioeconomic status.
To evaluate the association between socioeconomic factors and use of a DOAC (rivaroxaban,
dabigatran, or apixaban) or standard of care (warfarin) in patients with NVAF in Sweden.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02705976 -
Prospective Trial of a Validated Algorithm for Warfarin Dosing
|
N/A | |
| Active, not recruiting |
NCT04139525 -
Comparison of Citrate and Heparin Anticoagulation During Hemodialysis With MCO PES-PVP (Theranova) Membrane
|
N/A | |
| Completed |
NCT01907048 -
Patient and Physician Knowledge of Key Safety Messages
|
||
| Recruiting |
NCT03419923 -
Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage
|
N/A | |
| Completed |
NCT03575936 -
Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic
|
N/A | |
| Completed |
NCT02714855 -
Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France
|
N/A | |
| Recruiting |
NCT01314235 -
Influence of Clonidine on Thrombozytes of Blood of Patients Under Anticoagulation Therapy With ASS and Clopidogrel
|
N/A | |
| Withdrawn |
NCT04059965 -
AntiCoagulation Tracking InterVention and Evaluation
|
N/A | |
| Recruiting |
NCT02987192 -
Minimally Invasive Lumbar Aneasthesia Used for Cesarean Section
|
N/A | |
| Completed |
NCT01477528 -
Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
|
||
| Recruiting |
NCT04405232 -
Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK
|
||
| Recruiting |
NCT02761941 -
Excessive Warfarin Anticoagulation - Causes and Consequences
|
N/A | |
| Completed |
NCT02392104 -
Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service
|
N/A | |
| Completed |
NCT01884337 -
Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery
|
Phase 4 | |
| Recruiting |
NCT03473132 -
Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)
|
Phase 4 | |
| Enrolling by invitation |
NCT05305612 -
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
|
Phase 4 | |
| Completed |
NCT03662594 -
Growth of High-Quality Oxides on The Inner Surface of ECMO Circuit by ALD to Reduce Thrombus Formation
|
N/A | |
| Active, not recruiting |
NCT03910933 -
Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative
|
||
| Completed |
NCT02492828 -
Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden
|
N/A | |
| Completed |
NCT01124058 -
Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
|
Phase 1 |